Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges

Dogs with visceral leishmaniasis play a key role in the transmission cycle of <i>Leishmania infantum</i> to humans in the urban environment. There is a consensus regarding the importance of developing a vaccine to control this disease. Despite many efforts to develop a protective vaccine...

Full description

Bibliographic Details
Main Authors: Jaqueline Costa Leite, Ana Alice Maia Gonçalves, Diana Souza de Oliveira, Lucilene Aparecida Resende, Diego Fernandes Vilas Boas, Helen Silva Ribeiro, Diogo Fonseca Soares Pereira, Augusto Ventura da Silva, Reysla Maria da Silveira Mariano, Pedro Campos Carvalhaes Reis, Eiji Nakasone Nakasone, João Carlos França-Silva, Alexsandro Sobreira Galdino, Paulo Ricardo de Oliveira Paes, Marília Martins Melo, Edelberto Santos Dias, Miguel Angel Chávez-Fumagalli, Denise da Silveira-Lemos, Walderez Ornelas Dutra, Rodolfo Cordeiro Giunchetti
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/10/1565
_version_ 1797572072905375744
author Jaqueline Costa Leite
Ana Alice Maia Gonçalves
Diana Souza de Oliveira
Lucilene Aparecida Resende
Diego Fernandes Vilas Boas
Helen Silva Ribeiro
Diogo Fonseca Soares Pereira
Augusto Ventura da Silva
Reysla Maria da Silveira Mariano
Pedro Campos Carvalhaes Reis
Eiji Nakasone Nakasone
João Carlos França-Silva
Alexsandro Sobreira Galdino
Paulo Ricardo de Oliveira Paes
Marília Martins Melo
Edelberto Santos Dias
Miguel Angel Chávez-Fumagalli
Denise da Silveira-Lemos
Walderez Ornelas Dutra
Rodolfo Cordeiro Giunchetti
author_facet Jaqueline Costa Leite
Ana Alice Maia Gonçalves
Diana Souza de Oliveira
Lucilene Aparecida Resende
Diego Fernandes Vilas Boas
Helen Silva Ribeiro
Diogo Fonseca Soares Pereira
Augusto Ventura da Silva
Reysla Maria da Silveira Mariano
Pedro Campos Carvalhaes Reis
Eiji Nakasone Nakasone
João Carlos França-Silva
Alexsandro Sobreira Galdino
Paulo Ricardo de Oliveira Paes
Marília Martins Melo
Edelberto Santos Dias
Miguel Angel Chávez-Fumagalli
Denise da Silveira-Lemos
Walderez Ornelas Dutra
Rodolfo Cordeiro Giunchetti
author_sort Jaqueline Costa Leite
collection DOAJ
description Dogs with visceral leishmaniasis play a key role in the transmission cycle of <i>Leishmania infantum</i> to humans in the urban environment. There is a consensus regarding the importance of developing a vaccine to control this disease. Despite many efforts to develop a protective vaccine against CVL, the ones currently available, Leish-tec<sup>®</sup> and LetiFend<sup>®</sup>, have limited effectiveness. This is due, in part, to the complexity of the immune response of the naturally infected dogs against the parasite and the complexity of the parasite transmission cycle. Thus, strategies, such as the development of a transmission-blocking vaccines (TBVs) already being applied to other vector-borne diseases like malaria and dengue, would be an attractive alternative to control leishmaniasis. TBVs induce the production of antibodies in the vertebrate host, which can inhibit parasite development in the vector and/or interfere with aspects of vector biology, leading to an interruption of parasite transmission. To date, there are few TBV studies for CVL and other leishmaniasis forms. However, the few studies that exist show promising results, thus justifying the further development of this approach.
first_indexed 2024-03-10T20:49:36Z
format Article
id doaj.art-246e2991f7244796a6f26978882c81de
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T20:49:36Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-246e2991f7244796a6f26978882c81de2023-11-19T18:24:38ZengMDPI AGVaccines2076-393X2023-10-011110156510.3390/vaccines11101565Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New ChallengesJaqueline Costa Leite0Ana Alice Maia Gonçalves1Diana Souza de Oliveira2Lucilene Aparecida Resende3Diego Fernandes Vilas Boas4Helen Silva Ribeiro5Diogo Fonseca Soares Pereira6Augusto Ventura da Silva7Reysla Maria da Silveira Mariano8Pedro Campos Carvalhaes Reis9Eiji Nakasone Nakasone10João Carlos França-Silva11Alexsandro Sobreira Galdino12Paulo Ricardo de Oliveira Paes13Marília Martins Melo14Edelberto Santos Dias15Miguel Angel Chávez-Fumagalli16Denise da Silveira-Lemos17Walderez Ornelas Dutra18Rodolfo Cordeiro Giunchetti19Laboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilMicroorganism Biotechnology Laboratory, Federal University of São João Del-Rei (UFSJ), Midwest Campus, Divinópolis 35501-296, MG, BrazilDepartment of Veterinary Clinic and Surgery, School of Veterinary, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilDepartment of Veterinary Clinic and Surgery, School of Veterinary, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilRené Rachou Research Center, Oswaldo Cruz Foundation, Belo Horizonte 30190-002, MG, BrazilComputational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, Arequipa 04000, PeruLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilLaboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, BrazilDogs with visceral leishmaniasis play a key role in the transmission cycle of <i>Leishmania infantum</i> to humans in the urban environment. There is a consensus regarding the importance of developing a vaccine to control this disease. Despite many efforts to develop a protective vaccine against CVL, the ones currently available, Leish-tec<sup>®</sup> and LetiFend<sup>®</sup>, have limited effectiveness. This is due, in part, to the complexity of the immune response of the naturally infected dogs against the parasite and the complexity of the parasite transmission cycle. Thus, strategies, such as the development of a transmission-blocking vaccines (TBVs) already being applied to other vector-borne diseases like malaria and dengue, would be an attractive alternative to control leishmaniasis. TBVs induce the production of antibodies in the vertebrate host, which can inhibit parasite development in the vector and/or interfere with aspects of vector biology, leading to an interruption of parasite transmission. To date, there are few TBV studies for CVL and other leishmaniasis forms. However, the few studies that exist show promising results, thus justifying the further development of this approach.https://www.mdpi.com/2076-393X/11/10/1565canine visceral leishmaniasisvaccinestransmission-blocking vaccines
spellingShingle Jaqueline Costa Leite
Ana Alice Maia Gonçalves
Diana Souza de Oliveira
Lucilene Aparecida Resende
Diego Fernandes Vilas Boas
Helen Silva Ribeiro
Diogo Fonseca Soares Pereira
Augusto Ventura da Silva
Reysla Maria da Silveira Mariano
Pedro Campos Carvalhaes Reis
Eiji Nakasone Nakasone
João Carlos França-Silva
Alexsandro Sobreira Galdino
Paulo Ricardo de Oliveira Paes
Marília Martins Melo
Edelberto Santos Dias
Miguel Angel Chávez-Fumagalli
Denise da Silveira-Lemos
Walderez Ornelas Dutra
Rodolfo Cordeiro Giunchetti
Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges
Vaccines
canine visceral leishmaniasis
vaccines
transmission-blocking vaccines
title Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges
title_full Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges
title_fullStr Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges
title_full_unstemmed Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges
title_short Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges
title_sort transmission blocking vaccines for canine visceral leishmaniasis new progress and yet new challenges
topic canine visceral leishmaniasis
vaccines
transmission-blocking vaccines
url https://www.mdpi.com/2076-393X/11/10/1565
work_keys_str_mv AT jaquelinecostaleite transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT anaalicemaiagoncalves transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT dianasouzadeoliveira transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT lucileneaparecidaresende transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT diegofernandesvilasboas transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT helensilvaribeiro transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT diogofonsecasoarespereira transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT augustoventuradasilva transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT reyslamariadasilveiramariano transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT pedrocamposcarvalhaesreis transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT eijinakasonenakasone transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT joaocarlosfrancasilva transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT alexsandrosobreiragaldino transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT pauloricardodeoliveirapaes transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT mariliamartinsmelo transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT edelbertosantosdias transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT miguelangelchavezfumagalli transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT denisedasilveiralemos transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT walderezornelasdutra transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges
AT rodolfocordeirogiunchetti transmissionblockingvaccinesforcaninevisceralleishmaniasisnewprogressandyetnewchallenges